• About
  • Blog
  1. Home
  2. Blog
  3. Companies
  4. CAH

Cardinal Health, Inc.(CAH)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Distribution
Cardinal Health, Inc. logo

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Latest News & Analysis

Business professional shaking hands with colleague in modern office with purple accents
Jul 15, 2025

Cardinal Health, Inc. Earnings Momentum and Strategic Growth Insights - Monexa AI

Explore Cardinal Health's strong earnings momentum, raised FY25 guidance, segment growth, and strategic initiatives shaping its competitive positioning and future outlook.

Read more →
Business executive presenting to colleagues in a modern office with glass walls and purple accents
Jul 11, 2025

Cardinal Health (CAH) Investor Day 2025: Strategic Growth and Financial Outlook Analysis

Cardinal Health's 2025 Investor Day reveals raised EPS guidance, segment growth focus, increased share repurchases, and pharmacy advocacy initiatives underpinning long-term value.

Read more →
Business professional reviews financial data on a laptop in a sleek office with a city skyline backdrop
Jul 2, 2025

Cardinal Health (CAH) Momentum Analysis: Strategic Growth, Earnings Surprises & Market Position

Explore Cardinal Health's recent earnings growth, strategic acquisitions, segment performance, and competitive stance shaping its momentum and investor outlook.

Read more →
Business analyst beside a digital financial chart in a boardroom with a purple hue
Jun 27, 2025

Cardinal Health (CAH): Strategic Pivot & Robust FY26 Outlook Analysis

Cardinal Health's latest guidance reveals a significant strategic pivot, with robust FY26 targets and a strong focus on high-margin segments.

Read more →
Business professionals meeting at a modern conference table with a city view and purple accents
Jun 16, 2025

Cardinal Health (CAH): Strategic Growth & Strong Financial Outlook

Cardinal Health's robust financial performance and strategic pivots, including a raised FY25 EPS outlook, signal strong momentum in healthcare.

Read more →
Businesswoman in modern office studies financial data on a digital screen with purple market trends in the background
Jun 12, 2025

Cardinal Health (CAH) Analysis: Earnings Surge & Strategic Shifts

Cardinal Health's stock surges on robust earnings guidance, strategic focus on specialty medicines, and innovative medical device launches.

Read more →
A professional graphic representing Cardinal Health (CAH) financial strength, dividend increase, and strategic growth in healthcare and medical devices.
Jun 11, 2025

Cardinal Health (CAH) Analysis: Earnings, Dividends, and Strategy

Explore Cardinal Health's latest moves, including a new medical device launch, strong Q3 FY2025 earnings, and a dividend increase, amidst evolving healthcare dynamics.

Read more →
Cardinal Health's strategic expansion in healthcare distribution with focus on a new prostate cancer imaging agent partnership and financial growth.
Apr 21, 2025

Cardinal Health (CAH): Strategic Expansion Amidst Strong Financials

Analysis of Cardinal Health's recent strategic moves, financial performance, and market position, highlighting its defensive value and growth in specialized segments.

Read more →
Cardinal Health financial analysis: strategic partnerships, OptumRx mitigation, and investment stability in healthcare.
Apr 9, 2025

Cardinal Health (CAH): Partnerships, Market Shifts, and Dividends

Cardinal Health navigates market shifts with strategic partnerships and a focus on dividend strength, despite OptumRx headwinds.

Read more →
Cardinal Health's financial strategy, new board members, trade tension responses, and dividend sustainability analysis.
Mar 20, 2025

Cardinal Health's Board, Trade Strategy & Financial Health: Investor Analysis

Analysis of Cardinal Health's board changes, trade strategy, and financial health. Key points include earnings acceleration, free cash flow concerns, and valuation.

Read more →
Cardinal Health strategic shift: New board members, focus on specialty markets, and financial challenges. Analyst outlook positive. Stay informed!
Mar 10, 2025

Cardinal Health (CAH): Board Changes Signal Strategic Shift

Cardinal Health's board gains healthcare analytics and cybersecurity expertise amid financial challenges. Strategic focus on specialty markets and dividend stability.

Read more →
Cardinal Health (CAH) stock analysis: Earnings, acquisitions, and market trends impacting CAH's performance in the healthcare sector.
Mar 3, 2025

Cardinal Health (CAH): Earnings, Acquisitions, and Market Analysis

Cardinal Health (CAH) navigates a dynamic healthcare market with strategic acquisitions and earnings acceleration, facing challenges from contract expiry and macro factors.

Read more →
Cardinal Health Strategic Growth: Navigating Market Headwinds and Capitalizing on Opportunities - A Comprehensive Financial Analysis.
Feb 28, 2025

Cardinal Health (CAH): Q2 Earnings, Acquisitions & Future Outlook

Cardinal Health (CAH) navigates headwinds with strategic acquisitions and a focus on specialty markets driving growth. Analyst upgrades and dividends reinforce stability.

Read more →
Cardinal Health Q2 2025 earnings analysis, strategic acquisitions, and market performance review.
Feb 27, 2025

Cardinal Health: Q2 Earnings, Strategic Moves & Market Analysis

Cardinal Health's Q2 earnings beat estimates, driven by strategic acquisitions and strong pharmaceutical segment performance. However, the OptumRx contract expiry poses challenges.

Read more →
Cardinal Health Q2 2025 earnings analysis: strategic acquisitions, dividend approval, and healthcare landscape navigation. Insights on financial performance, analyst sentiment, and future outlook.
Feb 26, 2025

Cardinal Health (CAH): Q2 Earnings, Acquisitions, and Analysis

Cardinal Health (CAH) navigates Q2 earnings beat amid OptumRx headwinds, strategic acquisitions, and cash flow concerns. Analysts raise targets, but challenges persist.

Read more →
Cardinal Health Q2 2025 earnings overview: revenue analysis, strategic acquisitions, and market outlook for investors. Stay informed about CAH performance.
Feb 21, 2025

Cardinal Health Q2 2025 Earnings Analysis: Key Takeaways and Strategic Implications

A comprehensive analysis of Cardinal Health's Q2 2025 earnings report, detailing segment performance, dividend news, strategic acquisitions, and market trends.

Read more →
Pharmaceutical products arranged on a clean surface.
Feb 18, 2025

Cardinal Health Q2 2025 Earnings: Key Takeaways and Impact

An in-depth update on CAH Q2 2025 earnings, strategic moves, and dividend news that shapes its market outlook.

Read more →

Professional-grade financial analysis tools for informed investment decisions.

Product

  • Features
  • Pricing

Resources

  • Blog
  • Knowledge Base
  • Community
  • Market Data

Company

  • About
  • Careers
  • Contact
  • Partners

Legal

  • Privacy
  • Terms
  • License
  • Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.